News Author: Jennifer Shepphird Publish date: February 1, 2016
Key clinical point: Robot-assisted and laparoscopic hysterectomy had long-term survival comparable to that of abdominal hysterectomy in patients w...
News Author: Jennifer Shepphird Publish date: February 1, 2016
Key clinical point: A recurrence risk score based on clinicopathologic features of ductal carcinoma in situ (DCIS) was associated with survival be...
News Author: Jennifer Shepphird Publish date: January 29, 2016
Key clinical point: Proton radiotherapy for childhood medulloblastoma resulted in similar survival outcomes to those of photon-based therapy and h...
News Author: Jennifer Shepphird Publish date: January 25, 2016
First-line, low-dose gemtuzumab ozogamicin significantly improved overall survival, compared with best supportive care in patients aged 61 years or ol...
News Author: Jennifer Shepphird Publish date: January 25, 2016
Key clinical point: In patients who relapsed after allogeneic hematopoietic stem-cell transplantation, anti-CD19 chimeric antigen receptor (CAR) T...
News Author: Jennifer Shepphird Publish date: January 25, 2016
Key clinical point: Peripheral T-cell lymphoma incidence, proportions of subtypes, and survival differed markedly among racial/ethnic subpopulatio...
News Author: Jennifer Shepphird Publish date: January 25, 2016
Key clinical point: In mast cells isolated from patients with systemic mastocytosis, the antibody-conjugate brentuximab-vedotin inhibited growth a...
News Author: Jennifer Shepphird Publish date: January 24, 2016
Key clinical point: Proper hydroxyurea dose in adults with sickle cell anemia was linked to higher fetal hemoglobin levels, less organ dysfunction...
News Author: Jennifer Shepphird Publish date: January 18, 2016
Key clinical point: Analysis of randomized trial data compared with observational data on mortality after breast cancer radiotherapy shows strikin...
News Author: Jennifer Shepphird Publish date: January 18, 2016
Key clinical point: The risk of breast cancer recurrence continues through 24 years after primary treatments, especially for estrogen receptor&nda...
News Author: Jennifer Shepphird Publish date: January 14, 2016
Key clinical point: Five-year survivors of childhood cancers have increased lifespans due in part to reduced rates of treatment-related late effec...
News Author: Jennifer Shepphird Publish date: January 11, 2016
Key clinical point: Volasertib showed activity against platinum-resistant or -refractory ovarian cancer; adverse effects were mostly hematologic a...
News Author: Jennifer Shepphird Publish date: January 9, 2016
Key clinical point: Chronic graft-versus-host disease (GVHD) after allogeneic stem cell transplantation with peripheral blood stem cells was less ...
News Author: Jennifer Shepphird Publish date: January 8, 2016
Key clinical point: Daratumumab monotherapy was clinically active and well tolerated in patients with multiple myeloma who were treated with at le...
News Author: Jennifer Shepphird Publish date: January 7, 2016
Key clinical point: The presence of KIR2DL5B was associated with worse outcomes in patients with chronic phase–chronic myeloid leukemia trea...
